Display options
Cite
Henderson D, Eslamian G, Poon D, et al. Republished: Immune checkpoint inhibitor induced large vessel vasculitis. Drug Ther Bull. 2020;59(2):29-31doi: 10.1136/dtb.2020.233496rep.
Henderson, D., Eslamian, G., Poon, D., Crabb, S., Jones, R., Sankey, P., Kularatne, B., Linch, M., & Josephs, D. (2021). Republished: Immune checkpoint inhibitor induced large vessel vasculitis. Drug and therapeutics bulletin, 59(2), 29-31. https://doi.org/10.1136/dtb.2020.233496rep
Henderson, Daisy, et al. "Republished: Immune checkpoint inhibitor induced large vessel vasculitis." Drug and therapeutics bulletin vol. 59,2 (2021): 29-31. doi: https://doi.org/10.1136/dtb.2020.233496rep
Henderson D, Eslamian G, Poon D, Crabb S, Jones R, Sankey P, Kularatne B, Linch M, Josephs D. Republished: Immune checkpoint inhibitor induced large vessel vasculitis. Drug Ther Bull. 2021 Feb;59(2):29-31. doi: 10.1136/dtb.2020.233496rep. Epub 2020 Oct 22. PMID: 33093074.
Copy Download .nbib Format: NLM
Share it on

Drug Ther Bull. 2021 Feb;59(2):29-31. doi: 10.1136/dtb.2020.233496rep. Epub 2020 Oct 22.

Republished: Immune checkpoint inhibitor induced large vessel vasculitis.

Drug and therapeutics bulletin

Daisy Henderson, Gelareh Eslamian, Daniel Poon, Simon Crabb, Robert Jones, Peter Sankey, Bihani Kularatne, Mark Linch, Debra Josephs

Affiliations

  1. Department of Palliative Care, Royal Free London NHS Foundation Trust, London, UK [email protected].
  2. Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  3. Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  4. Cancer Sciences Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
  5. Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  6. Department of Clinical Oncology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  7. Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
  8. Department of Oncology, University College London Cancer Institute, London, UK.

PMID: 33093074 DOI: 10.1136/dtb.2020.233496rep

[No abstract available.]

Keywords: cancer intervention; immunology; prostate cancer; unwanted effects / adverse reactions; vasculitis

Conflict of interest statement

Competing interests: None declared.

Publication Types